AKT1 and breast carcinoma: Phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway is one of the several self-renewal pathways existing in breast cancer cells [5,6,7] and inhibitors of this pathway may reduce ‘stemness’ of cancer cells.